Frontiers in Oncology (Oct 2021)
Corrigendum: Serum Biomarker Panel for Diagnosis and Prognosis of Pancreatic Ductal Adenocarcinomas
- Shreya Mehta,
- Shreya Mehta,
- Nazim Bhimani,
- Anthony J. Gill,
- Anthony J. Gill,
- Anthony J. Gill,
- Anthony J. Gill,
- Anthony J. Gill,
- Jaswinder S. Samra,
- Jaswinder S. Samra,
- Jaswinder S. Samra,
- Sumit Sahni,
- Sumit Sahni,
- Sumit Sahni,
- Anubhav Mittal,
- Anubhav Mittal,
- Anubhav Mittal
Affiliations
- Shreya Mehta
- Northern Clinical School, Faculty of Medicine and Health, University of Sydney, Sydney, NSW, Australia
- Shreya Mehta
- Kolling Institute of Medical Research, University of Sydney, Sydney, NSW, Australia
- Nazim Bhimani
- Upper Gastro Intestinal (GI) Surgical Unit, Royal North Shore Hospital and North Shore Private Hospital, Sydney, NSW, Australia
- Anthony J. Gill
- Northern Clinical School, Faculty of Medicine and Health, University of Sydney, Sydney, NSW, Australia
- Anthony J. Gill
- Kolling Institute of Medical Research, University of Sydney, Sydney, NSW, Australia
- Anthony J. Gill
- Cancer Diagnosis and Pathology Group, Kolling Institute of Medical Research, Royal North Shore Hospital, St Leonards, NSW, Australia
- Anthony J. Gill
- Australian Pancreatic Centre, Sydney, NSW, Australia
- Anthony J. Gill
- NSW Health Pathology, Department of Anatomical Pathology, Royal North Shore Hospital, St Leonards, NSW, Australia
- Jaswinder S. Samra
- Northern Clinical School, Faculty of Medicine and Health, University of Sydney, Sydney, NSW, Australia
- Jaswinder S. Samra
- Upper Gastro Intestinal (GI) Surgical Unit, Royal North Shore Hospital and North Shore Private Hospital, Sydney, NSW, Australia
- Jaswinder S. Samra
- Australian Pancreatic Centre, Sydney, NSW, Australia
- Sumit Sahni
- Northern Clinical School, Faculty of Medicine and Health, University of Sydney, Sydney, NSW, Australia
- Sumit Sahni
- Kolling Institute of Medical Research, University of Sydney, Sydney, NSW, Australia
- Sumit Sahni
- Australian Pancreatic Centre, Sydney, NSW, Australia
- Anubhav Mittal
- Northern Clinical School, Faculty of Medicine and Health, University of Sydney, Sydney, NSW, Australia
- Anubhav Mittal
- Upper Gastro Intestinal (GI) Surgical Unit, Royal North Shore Hospital and North Shore Private Hospital, Sydney, NSW, Australia
- Anubhav Mittal
- Australian Pancreatic Centre, Sydney, NSW, Australia
- DOI
- https://doi.org/10.3389/fonc.2021.774861
- Journal volume & issue
-
Vol. 11
Abstract
No abstracts available.Keywords
- pancreatic ductal adenocarcinoma
- diagnostic biomarkers
- prognostic biomarkers
- S100A4
- Ca-125 and Ca 19-9
- survival analysis